DEEPScreen: high performance drug-target interaction prediction with convolutional neural networks using 2-D structural compound representations

Download

index.pdf

Date

2020-03-07

Author

Rifaioğlu, Ahmet Süreyya
Nalbat, Esra
Atalay, Mehmet Volkan

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

339
views

160
downloads

The identification of physical interactions between drug candidate compounds and target biomolecules is an important process in drug discovery. Since conventional screening procedures are expensive and time consuming, computational approaches are employed to provide aid by automatically predicting novel drug-target interactions (DTIs). In this study, we propose a large-scale DTI prediction system, DEEPScreen, for early stage drug discovery, using deep convolutional neural networks. One of the main advantages of DEEPScreen is employing readily available 2-D structural representations of compounds at the input level instead of conventional descriptors that display limited performance. DEEPScreen learns complex features inherently from the 2-D representations, thus producing highly accurate predictions. The DEEPScreen system was trained for 704 target proteins (using curated bioactivity data) and finalized with rigorous hyper-parameter optimization tests. We compared the performance of DEEPScreen against the state-of-the-art on multiple benchmark datasets to indicate the effectiveness of the proposed approach and verified selected novel predictions through molecular docking analysis and literature-based validation. Finally, JAK proteins that were predicted by DEEPScreen as new targets of a well-known drug cladribine were experimentally demonstrated in vitro on cancer cells through STAT3 phosphorylation, which is the downstream effector protein. The DEEPScreen system can be exploited in the fields of drug discovery and repurposing for in silico screening of the chemogenomic space, to provide novel DTIs which can be experimentally pursued. The source code, trained "ready-to-use" prediction models, all datasets and the results of this study are available at ; https://github.com/cansyl/DEEPscreen.

Subject Keywords

Discovery, Ligand, Inhibitors, Cladribine, Renin, Derivatives, Docking, Potent, Design

URI

https://hdl.handle.net/11511/30169

Journal

CHEMICAL SCIENCE

DOI

https://doi.org/10.1039/c9sc03414e

Collections

Graduate School of Natural and Applied Sciences, Article

Suggestions

OpenMETU
Core

Hnet-DTI: Incorporating heterogeneous information network for drug-target interaction prediction Özsarı , Gökhan; Rifaioğlu , Ahmet Süreyya; Doğan , Tunca; Atalay, Volkan (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10) Identifying drug-target interactions (DTIs) is crucial in drug discovery. In silico prediction of interactions between drugs and target proteins is needed to accelerate the drug discovery process. Although many DTI prediction methods have been proposed in recent years, there is still room for improvement. This study proposes a graph neural network-based method to exploit the heterogeneous information network for drug-target interaction prediction. The study includes two major contributions: Heterogeneous in...
MDeePred: Novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery Rifaioglu, A.S.; Atalay, R. Cetin; Kahraman, Deniz Cansen; DOĞAN, TUNCA; Martin, M.; Atalay, Mehmet Volkan (2021-03-01) Motivation: Identification of interactions between bioactive small molecules and target proteins is crucial for novel drug discovery, drug repurposing and uncovering off-target effects. Due to the tremendous size of the chemical space, experimental bioactivity screening efforts require the aid of computational approaches. Although deep learning models have been successful in predicting bioactive compounds, effective and comprehensive featurization of proteins, to be given as input to deep neural networks, r...
3D analysis of the binding sites for predicting binding affinities in drug design Ataç, Ali Osman; Alpaslan, Ferda Nur; Büyükbingöl, Erdem; Department of Computer Engineering (2014) Understanding the interaction between drug molecules and proteins is one of the main challenges in drug design. Several tools have been developed recently to decrease the complexity of the process. Artificial intelligence and machine learning methods have promising results in predicting the affinities. Recently, accurate estimations have been performed by extracting the electrostatic potentials from images of the drug-protein binding sites which were generated by autodocking simulator. In this study, a new ...
Three-Dimensional Analysis of Binding Sites for Predicting Binding Affinities in Drug Design Erdas-Cicek, Ozlem; Atac, Ali Osman; Gurkan-Alp, A. Selen; Buyukbingol, Erdem; Alpaslan, Ferda Nur (American Chemical Society (ACS), 2019-11-01) Understanding the interaction between drug molecules and proteins is one of the main challenges in drug design. Several tools have been developed recently to decrease the complexity of the process. Artificial intelligence and machine learning methods offer promising results in predicting the binding affinities. It becomes possible to do accurate predictions by using the known protein-ligand interactions. In this study, the electrostatic potential values extracted from 3-dimensional grid cubes of the drug-pr...
Peptide-based diagnostic and therapeutic agents: Where we are and where we are heading? PARLAK KHALİLY, MELEK; Soydan, Medine (2022-11-01) Peptides are increasingly present in all branches of medicine as innovative drugs, imaging agents, theragnostic, and constituent moieties of other sophisticated drugs such as peptide-drug conjugates. Due to new developments in chemical synthesis strategies, computational biology, recombinant technology, and chemical biology, peptide drug development has made a great progress in the last decade. Numerous natural peptides and peptide mimics have been obtained and studied, covering multiple therapeutic areas. ...

Citation Formats

A. S. Rifaioğlu, E. Nalbat, and M. V. Atalay, “DEEPScreen: high performance drug-target interaction prediction with convolutional neural networks using 2-D structural compound representations,” CHEMICAL SCIENCE, pp. 2531–2557, 2020, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/30169.